Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
Open accessThe DOI matches its Crossref record; 44 of the 45 references it cites were found in a registry or an index.
Abstract
Manipulation of a transcriptional repressor promotes expression of protective fetal globin genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the degree of γ -globin induction is substantially less than that seen with BCL11A de fi ciency (8).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [8]
In the citing paper
“Reducing bcl11a expression in transgenic sickle mice derepressed g-globin genes.17,18”
From Fetal hemoglobin in sickle cell anemia (2020) · cites this paper as [18]
In the citing paper
“However, deletion of BCL11A in mouse results in much greater increases (31.2- to 232.9-fold) of embryonic globin genes in de fi nitive fetal liver and bone marrow erythroid cells (Fig. 4 C and E ) (8)”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [8]
In the citing paper
“Most importantly, inactivation of BCL11A alone is suf fi cient to ameliorate the hematologic and pathologic defects associated with SCD through high-level HbF induction in humanized mouse models (8).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [8]
In the citing paper
“DNA methylation plays an important role in globin gene expression, and DNA demethylating agents have been shown to induce HbF expression in various model systems and patients (8, 17, 18).”
From Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A (2013) · cites this paper as [8]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection.
Li, C., & Wong, W. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.1.31 · Cited by 3,133
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection
Lanford, R. E., Hildebrandt-Eriksen, E. S., Petri, A., Persson, R., Lindow, M., Munk, M. E., Kauppinen, S., & Ørum, H. (2010) · Science · doi:10.1126/science.1178178 · Cited by 1,459
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin
Hanna, J., Wernig, M., Markoulaki, S., Sun, C.-W., Meissner, A., Cassady, J. P., Beard, C., Brambrink, T., Wu, L.-C., Townes, T. M., et al. (2007) · Science · doi:10.1126/science.1152092 · Cited by 1,202
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Sankaran, V. G., Menne, T. F., Xu, J., Akie, T. E., Lettre, G., Van Handel, B., Mikkola, H. K. A., Hirschhorn, J. N., Cantor, A. B., & Orkin, S. H. (2008) · Science · doi:10.1126/science.1165409 · Cited by 919
Self-citationA Specific Chemical Difference Between the Globins of Normal Human and Sickle-Cell Anæmia Hæmoglobin
INGRAM, V. M. (1956) · Nature · doi:10.1038/178792a0 · Cited by 896
Direct inhibition of the NOTCH transcription factor complex
Moellering, R. E., Cornejo, M., Davis, T. N., Bianco, C. D., Aster, J. C., Blacklow, S. C., Kung, A. L., Gilliland, D. G., Verdine, G. L., & Bradner, J. E. (2009) · Nature · doi:10.1038/nature08543 · Cited by 752
Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910.
Jb, H. (2001) · PubMed Central · Cited by 676
Cited by
Items 301–327 of 327
Sickle cell anemia: HBB haplotypes; clinical heterogeneity; iPSC modeling
Vanuytsel, K., Steinberg, M. H., & Murphy, G. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-822227-0.00002-8 · Cited by 1
Obeidi, N., Tamaddon, G., Ranjbaran, R., Khamisipour, G., & Saberi, F. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100934
MiR-144 Regulates Hemoglobin Expression in Human Erythroid Cell Line
Penglong, T., Saensuwanna, A., Kocharoenwat, J., BOORINTARAGOT, W., FUPONGSIRIPHAN, S., & Srinoun, K. (2020) · Walailak Journal of Science and Technology (WJST) · doi:10.48048/wjst.2020.10712
“Besides NRF2, previous report had demonstrated that BCL11A was a repressor of γ-globin expression during hemoglobin switching [7,8,19].”
Background(2021) · Wiley eBooks · doi:10.1002/9781119836070.refs
Grand Celebration: 10th Anniversary of the Human Genome Project
Rampelotto, P. H., Burn, J., Lupski, J., & Nelson, K. (2016) · MDPI eBooks · doi:10.3390/books978-3-03842-170-2
Arora, M. (2013) · 实验材料和方法 · doi:10.13070/mm.cn.3.175
Complex Disease Genes and Their Discovery
Barrett, J. C., & Daly, M. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-28703-0_4
Blood components from pluripotent stem cells
Kimbrel, E. A., & Lanza, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818422-6.00043-5
Reactivate expression of fetal hemoglobin In CD34+ primary adult erythroid cells by gene therapy
Leela-adisorn, N. (2016) · Chula Digiverse · doi:10.58837/chula.the.2016.1712
Applied Stem Cell Research in Sickle Cell Disease
Kiumarsi, A., Rostami, T., & Mohammadi, M. S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00027-5
Fibrillarin modulates fetal hemoglobin silencingPreprint
Wu, D., Li, Q., Qiu, S., Guo, C., Li, F., Shangguan, W., Li, W., Yang, D., Meng, X., Xing, M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.25.600532
Wang, L., He, H., Li, Y., Wang, X., Yu, J., Huang, Y., Yu, K., He, J., Zhao, M., Xie, T., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155717
Revisiting γ-globin gene repression by TR4
Perkins, A. C. (2024) · Blood · doi:10.1182/blood.2024026481
RNA Editors Sculpt the Transcriptome During Terminal ErythropoiesisPreprint
Han, A., Yermalovich, A. V., Najia, M. A. T., Pearson, D. S., Fujiwara, Y., Bolgov, M., Kubaczka, C., North, T. E., Lundin, V., Orkin, S. H., et al. (2025) · Research Square · doi:10.1101/2025.04.03.647020 · Cited by 1
“This experiment of nature has inspired a therapeutic strategy to reactivate fetal γ-globin via genetic perturbation of the γ-globin repressor BCL11A, resulting in transcriptional reactivation and considerable clinical improvement for SCD patients 44,49,57,58 .”
Self-citationSegura, E. (2025) · eScholarship (California Digital Library)
Disrupting epigenetic insulation underlies CRISPR therapy for β-hemoglobinopathies
Wang, K., Wang, J., Weiss, M. J., Yue, F., & Xu, J. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.12.015
Self-citationYounus, L. A., Al-Zubaidy, H. F. S., Abdulrudha, K. H., Nasser, F. A., & Kudhair, A. H. (2025) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-025-00824-2 · Cited by 1
“Using a mouse model of sickle cell disease, Xu et al. [25] show that disrupting BCL11A activity raises fetal hemoglobin levels, which lessens the severity of the illness.”
Therapeutic Genome Engineering for the Treatment of Sickle Cell Disease
Leonard, A. K., Sharma, A., Chao, F.-Y., & Yen, J. S. (2026) · Springer eBooks · doi:10.1007/978-3-032-12532-3_9 · Cited by 1
Tishkoff, S. A. (2026) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2026.02.013
Antoniani, C. (2017) · theses.fr (ABES) · doi:10.70675/fa4f556cza36dz42efz9910zbd602b77cff5
Etude des régulateurs et des voies moléculaires impliqués dans les conversions d'état cellulaire
Trajkova, A. (2024) · theses.fr (ABES) · doi:10.70675/87dd8564zbfd1z4a6ezbc15z8a3402efe338
Reversible regulation of γ-globin expression by LRF through a BCL11A-independent mechanism
Miyazaki, M., Setoguchi, K., Masuda, T., Morikawa, T., Mehta, S., Matsumoto, S., Kunisaki, Y., Orkin, S. H., Semba, Y., & Maeda, T. (2026) · Blood Red Cells & Iron · doi:10.1016/j.brci.2026.100087
Self-citationThe Journey of Gene Therapy in Sickle Cell Disease: How Molecular Advances Meet Clinical Care
Tardif, M., Saby, M., Forté, S., & Pincez, T. (2026) · Cells · doi:10.3390/cells15100939
“Deletion of BCL11A , which is a cause of HPFH [37], effectively restores HbF expression [38], validating BCL11A loss as a potential avenue.”
Eldin, A. M. K., Abdelnaem, E. A., Mohamed, N. Z., Mohamed, F. I., Elsayed, M. A., & Keryakos, H. K. H. (2026) · Journal of Hematopathology · doi:10.1007/s12308-026-00698-2
Cooperative Repression of γ-Globin by LYAR and NONO
Wu, D., Shangguan, W., Wang, X., Liu, T., Li, W., Liao, R., Meng, X., Xing, M., Zhu, Y., Zhang, R., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113702
Metadata
- Authors
- Xu, J., Peng, C., Sankaran, V. G., Shao, Z., Esrick, E. B., Chong, B. G., Ippolito, G. C., Fujiwara, Y., Ebert, B. L., Tucker, P. W., & Orkin, S. H.
- Affiliations
- Boston Children's Hospital (US)
- Broad Institute (US)
- Brigham and Women's Hospital (US)
- The University of Texas at Austin (US)
- Corresponding author
- Peng, Cong
- Sankaran, Vijay G.
- Orkin, Stuart H.
- ORCID
- Venue
- Science
- Published
- 2011-11-18
- Volume
- 334
- Issue
- 6058
- Pages
- 993-996
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3746545
- OpenAlex
- W2033380734
- Cited by
- 326
- References
- 45
- Citations by year
- 2026: 10 · 2025: 15 · 2024: 16 · 2023: 13 · 2022: 18 · 2021: 20 · 2020: 22 · 2019: 18 · 2018: 25 · 2017: 24 · 2016: 42 · 2015: 26 · 2014: 23 · 2013: 32 · 2012: 19
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (T32CA009172)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK093543)
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Keywords
- sickle cell disease, fetal hemoglobin, BCL11A, beta-thalassemia, transgenic mice, therapeutic target, erythropoiesis
- MeSH terms
- Anemia, Sickle Cell, Animals, Carrier Proteins, DNA-Binding Proteins, Embryo, Mammalian, Fetal Hemoglobin, Gene Expression Regulation, Histones, Humans, Mice, Transgenic, Nuclear Proteins, Repressor Proteins, Mice, Knockout, DNA Methylation, Gene Silencing, Erythroid Cells, Epigenesis, Genetic, Mice, gamma-Globins, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.